(Q37547111)

English

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease

scientific article published on 30 December 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease (English)

1 reference

Europe PubMed Central

20 August 2017

author name string

Elizabeth R Volkmann

1

1 reference

Europe PubMed Central

20 August 2017

Donald P Tashkin

2

1 reference

Europe PubMed Central

20 August 2017

Michael D Roth

3

1 reference

Europe PubMed Central

20 August 2017

Philip J Clements

4

1 reference

Europe PubMed Central

20 August 2017

Dinesh Khanna

5

1 reference

Europe PubMed Central

20 August 2017

Daniel E Furst

6

1 reference

Europe PubMed Central

20 August 2017

Maureen Mayes

7

1 reference

Europe PubMed Central

20 August 2017

Julio Charles

8

1 reference

Europe PubMed Central

20 August 2017

Chi-Hong Tseng

9

1 reference

Europe PubMed Central

20 August 2017

Robert M Elashoff

10

1 reference

Europe PubMed Central

20 August 2017

Shervin Assassi

11

1 reference

Europe PubMed Central

20 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 December 2016

1 reference

Europe PubMed Central

20 August 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

20 August 2017

18

1 reference

Europe PubMed Central

20 August 2017

1

1 reference

Europe PubMed Central

20 August 2017

305

1 reference

Europe PubMed Central

20 August 2017

https://scigraph.springernature.com/pub.10.1186/s13075-016-1203-y

0 references

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

23 August 2017

Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

23 August 2017

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

23 August 2017

Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

23 August 2017

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

23 August 2017

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

23 August 2017

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

23 August 2017

Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

23 August 2017

Predictors of end stage lung disease in a cohort of patients with scleroderma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

23 August 2017

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

6 September 2017

Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

1 September 2018

Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

1 September 2018

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

1 September 2018

CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

1 September 2018

Interstitial lung disease in systemic sclerosis: a simple staging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203703

1 September 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1186%2FS13075-016-1203-Y

21 January 2018

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

1 reference

https://api.crossref.org/works/10.1186%2FS13075-016-1203-Y

21 January 2018

Prediction of pulmonary complications and long-term survival in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28038680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28038680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline

1 reference

https://pubmed.ncbi.nlm.nih.gov/28038680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28038680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interstitial lung disease in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28038680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28038680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/28038680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S13075-016-1203-Y

1 reference

Europe PubMed Central

20 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37547111&oldid=1710706353"